KY Biotechnology & Medical Research

ProKidney Corp (PROK)

Track

The most recent insider trading activity at ProKidney Corp occurred on November 13, 2025, involving multiple sell transactions by Director Brian Pereira. These sales followed a series of proposed and executed divestments by the same insider in November 2025. Prior to these sales, the company saw significant buying activity from institutional insiders in April 2025.
Ticker: PROK Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sale 13 Nov 2025
Value US$3,052,675.41 | Price 234.42 | Shares 5,438 (+4.4%)
Sale 13 Nov 2025
Value US$3,196,696.33 | Price 108.15 | Shares 20,824 (+48.5%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-14 2025-11-13 S Sale
3.4
Pereira Brian JG
Non-Executive Director
5,438 +4.4%
234.42
US$3,052,675 		5,438 +4.4% 234.42 US$3,052,675
2025-11-14 2025-11-13 S Sale
3.4
Pereira Brian JG
Non-Executive Director
20,824 +48.5%
108.15
US$3,196,696 		20,824 +48.5% 108.15 US$3,196,696
2025-11-14 2025-11-12 S Sale
3.4
Pereira Brian JG
Non-Executive Director
83,448 +12.9%
219.69
US$1,120,666 		83,448 +12.9% 219.69 US$1,120,666
2025-11-14 2025-11-12 S Sale
3.4
Pereira Brian JG
Non-Executive Director
227,431 -33.7%
2.72
US$619,363 		227,431 -33.7% 2.72 US$619,363
2025-11-12 2025-11-12 PrS Proposed sale
3.4
Brian Pereira

Director

Non-Executive Director
675,234
2.70
US$1,823,131 		675,234 2.70 US$1,823,131
2025-11-12 2025-11-12 PrS Proposed sale
3.4
Brian Pereira

Director

Non-Executive Director
81,928
2.70
US$221,205 		81,928 2.70 US$221,205
2025-07-09 2025-07-08 PlS Planned sale
Weber Darin J.

Chief Regulatory Officer

Officer
103,480 -100.0%
3.02
US$312,510 		103,480 -100.0% 3.02 US$312,510
2025-07-08 2025-07-08 PrS Proposed sale
DARIN J WEBER

Officer

Officer
103,480
0.61
US$62,761 		103,480 0.61 US$62,761
2025-04-24 2025-04-22 B Purchase
3.0
Control Empresarial de Capitales S.A. de C.V.

Add'l Rep. Persons-see Ex.99-1

Large shareholder
387,393 +0.5%
0.71
US$276,366 		387,393 +0.5% 0.71 US$276,366
2025-04-21 2025-04-17 B Purchase
3.0
Control Empresarial de Capitales S.A. de C.V.

Add'l Rep. Persons-see Ex.99-1

Large shareholder
25,000 +0.0%
0.75
US$18,690 		25,000 +0.0% 0.75 US$18,690
2025-04-18 2025-04-16 B Purchase
3.0
Control Empresarial de Capitales S.A. de C.V.

Add'l Rep. Persons-see Ex.99-1

Large shareholder
100,000 +0.1%
0.75
US$74,820 		100,000 +0.1% 0.75 US$74,820
2025-04-16 2025-04-15 B Purchase
3.0
Control Empresarial de Capitales S.A. de C.V.

Add'l Rep. Persons-see Ex.99-1

Large shareholder
468,000 +0.6%
0.70
US$326,009 		468,000 +0.6% 0.70 US$326,009
2025-04-16 2025-04-14 B Purchase
3.0
Control Empresarial de Capitales S.A. de C.V.

Add'l Rep. Persons-see Ex.99-1

Large shareholder
268,105 +0.4%
0.73
US$194,591 		268,105 +0.4% 0.73 US$194,591
2025-04-14 2025-04-11 B Purchase
3.0
Control Empresarial de Capitales S.A. de C.V.

Add'l Rep. Persons-see Ex.99-1

Large shareholder
1,900 +0.0%
0.61
US$1,155 		1,900 +0.0% 0.61 US$1,155
2025-04-14 2025-04-10 B Purchase
3.0
Control Empresarial de Capitales S.A. de C.V.

Add'l Rep. Persons-see Ex.99-1

Large shareholder
1,032,218 +1.4%
0.61
US$627,692 		1,032,218 +1.4% 0.61 US$627,692
2024-09-20 2024-09-19 PlS Planned sale
Weber Darin J.

Chief Regulatory Officer

Officer
16,412 -13.7%
2.50
US$41,030 		16,412 -13.7% 2.50 US$41,030
2024-09-19 2024-09-19 PrS Proposed sale
DARIN J WEBER

Officer

Officer
16,412
2.39
US$39,225 		16,412 2.39 US$39,225
2024-07-29 2024-07-26 PlS Planned sale
Weber Darin J.

Chief Regulatory Officer

Officer
826 -0.7%
2.50
US$2,065 		826 -0.7% 2.50 US$2,065
2024-06-20 2024-06-18 PlS Planned sale
Weber Darin J.

Chief Regulatory Officer

Officer
17,238 -12.5%
2.82
US$48,616 		17,238 -12.5% 2.82 US$48,616
2024-06-14 2024-06-13 B Purchase
1.7
Legorreta Pablo G.
Non-Executive Director Large shareholder
22,617,909 +inf%
2.42
US$54,735,340 		22,617,909 +inf% 2.42 US$54,735,340
2024-06-25 2024-06-11 B Purchase
3.0
Control Empresarial de Capitales S.A. de C.V.

Add'l Rep. Persons-see Ex.99-1

Large shareholder
8,264,462 +13.1%
2.42
US$19,999,998 		8,264,462 +13.1% 2.42 US$19,999,998
2024-05-22 2024-05-20 PlS Planned sale
Weber Darin J.

Chief Regulatory Officer

Officer
17,238 -11.1%
4.08
US$70,386 		17,238 -11.1% 4.08 US$70,386
2024-05-22 2024-05-20 PlS Planned sale
Weber Darin J.

Chief Regulatory Officer

Officer
17,238 -11.1%
4.08
US$70,386 		17,238 -11.1% 4.08 US$70,386
2024-05-20 2024-05-20 PrS Proposed sale
DARIN J WEBER

Officer

Officer
68,952
4.06
US$279,600 		68,952 4.06 US$279,600
2024-04-23 2024-04-22 PlS Planned sale
Weber Darin J.

SVP of Regulatory Development

Officer
16,438 -9.6%
2.51
US$41,315 		16,438 -9.6% 2.51 US$41,315
2024-04-23 2024-04-18 PlS Planned sale
Weber Darin J.

SVP of Regulatory Development

Officer
800 -0.5%
2.54
US$2,028 		800 -0.5% 2.54 US$2,028
2024-04-18 2024-04-18 PrS Proposed sale
DARIN J WEBER

Officer

Officer
17,238
2.84
US$48,956 		17,238 2.84 US$48,956
2024-04-17 2024-04-16 PlS Planned sale
Weber Darin J.

SVP of Regulatory Development

Officer
17,238 -9.1%
2.50
US$43,095 		17,238 -9.1% 2.50 US$43,095
2024-04-16 2024-04-16 PrS Proposed sale
DARIN J WEBER

Officer

Officer
17,238
2.09
US$36,027 		17,238 2.09 US$36,027
2024-04-16 2024-04-12 PlS Planned sale
Weber Darin J.

SVP of Regulatory Development

Officer
84,103 -30.7%
1.73
US$145,498 		84,103 -30.7% 1.73 US$145,498
2024-04-12 2024-04-12 PrS Proposed sale
DARIN J WEBER

Officer

Officer
84,103
1.64
US$137,929 		84,103 1.64 US$137,929
2024-04-16 2024-04-01 PlS Planned sale
Weber Darin J.

SVP of Regulatory Development

Officer
300 -0.1%
1.69
US$507 		300 -0.1% 1.69 US$507
2024-04-01 2024-04-01 PrS Proposed sale
DARIN J WEBER

Officer

Officer
300
1.64
US$492 		300 1.64 US$492
2024-05-16 2024-03-25 B Purchase
3.0
Control Empresarial de Capitales S.A. de C.V.

Add'l Rep. Persons-see Ex.99-1

Large shareholder
30,000 +0.0%
1.43
US$42,954 		30,000 +0.0% 1.43 US$42,954
2024-05-16 2024-03-22 B Purchase
3.0
Control Empresarial de Capitales S.A. de C.V.

Add'l Rep. Persons-see Ex.99-1

Large shareholder
14,000 +0.0%
1.40
US$19,586 		14,000 +0.0% 1.40 US$19,586
2024-05-16 2024-03-20 B Purchase
3.0
Control Empresarial de Capitales S.A. de C.V.

Add'l Rep. Persons-see Ex.99-1

Large shareholder
33,000 +0.1%
1.40
US$46,111 		33,000 +0.1% 1.40 US$46,111
2024-05-16 2024-03-14 B Purchase
3.0
Control Empresarial de Capitales S.A. de C.V.

Add'l Rep. Persons-see Ex.99-1

Large shareholder
50,000 +0.1%
1.36
US$67,925 		50,000 +0.1% 1.36 US$67,925
2024-05-16 2024-03-13 B Purchase
3.0
Control Empresarial de Capitales S.A. de C.V.

Add'l Rep. Persons-see Ex.99-1

Large shareholder
50,000 +0.1%
1.50
US$75,090 		50,000 +0.1% 1.50 US$75,090
2023-11-21 2023-11-19 S Sale
2.9
Palihapitiya Chamath
2,073,000 -100.0%
1.31
US$2,713,557 		2,073,000 -100.0% 1.31 US$2,713,557
2023-11-21 2023-11-19 S Sale
2.9
Palihapitiya Chamath
5,183,367 -100.0%
1.31
US$6,785,027 		5,183,367 -100.0% 1.31 US$6,785,027
2023-11-17 2023-11-17 S Sale
2.9
Palihapitiya Chamath
Large shareholder
258,400 -4.7%
1.19
US$308,400 		258,400 -4.7% 1.19 US$308,400
2023-11-17 2023-11-16 S Sale
2.9
Palihapitiya Chamath
Large shareholder
212,100 -3.8%
1.22
US$259,398 		212,100 -3.8% 1.22 US$259,398
2023-11-17 2023-11-15 S Sale
2.9
Palihapitiya Chamath
Large shareholder
282,300 -4.8%
1.49
US$420,147 		282,300 -4.8% 1.49 US$420,147
2023-11-14 2023-11-14 S Sale
2.9
Palihapitiya Chamath
Large shareholder
306,200 -4.9%
1.50
US$459,086 		306,200 -4.9% 1.50 US$459,086
2023-11-14 2023-11-13 S Sale
2.9
Palihapitiya Chamath
Large shareholder
88,700 -1.4%
1.57
US$139,676 		88,700 -1.4% 1.57 US$139,676
2023-11-14 2023-11-10 S Sale
2.9
Palihapitiya Chamath
Large shareholder
85,900 -1.3%
1.61
US$138,411 		85,900 -1.3% 1.61 US$138,411
2023-11-14 2023-11-09 S Sale
2.9
Palihapitiya Chamath
Large shareholder
95,900 -1.5%
1.68
US$160,700 		95,900 -1.5% 1.68 US$160,700
2023-11-08 2023-11-08 S Sale
2.9
Palihapitiya Chamath
Large shareholder
59,000 -0.9%
1.66
US$97,763 		59,000 -0.9% 1.66 US$97,763
2023-11-08 2023-11-07 S Sale
2.9
Palihapitiya Chamath
Large shareholder
71,233 -1.1%
1.59
US$113,367 		71,233 -1.1% 1.59 US$113,367
2023-11-08 2023-11-06 S Sale
2.9
Palihapitiya Chamath
Large shareholder
79,600 -1.2%
1.56
US$123,818 		79,600 -1.2% 1.56 US$123,818
2023-11-03 2023-11-03 S Sale
2.9
Palihapitiya Chamath
Large shareholder
148,300 -2.2%
1.73
US$256,470 		148,300 -2.2% 1.73 US$256,470
2023-11-03 2023-11-02 S Sale
2.9
Palihapitiya Chamath
Large shareholder
133,700 -1.9%
1.73
US$231,956 		133,700 -1.9% 1.73 US$231,956
2023-11-03 2023-11-01 S Sale
2.9
Palihapitiya Chamath
Large shareholder
123,400 -1.7%
1.62
US$199,674 		123,400 -1.7% 1.62 US$199,674
2023-10-31 2023-10-31 S Sale
2.9
Palihapitiya Chamath
Large shareholder
141,900 -2.0%
1.69
US$239,300 		141,900 -2.0% 1.69 US$239,300
2023-10-31 2023-10-30 S Sale
2.9
Palihapitiya Chamath
Large shareholder
157,000 -2.1%
1.65
US$259,537 		157,000 -2.1% 1.65 US$259,537
2023-10-31 2023-10-27 S Sale
2.9
Palihapitiya Chamath
Large shareholder
92,500 -1.2%
1.59
US$146,677 		92,500 -1.2% 1.59 US$146,677
2023-10-26 2023-10-26 S Sale
2.9
Palihapitiya Chamath
Large shareholder
77,960 -1.0%
1.80
US$140,577 		77,960 -1.0% 1.80 US$140,577
2023-10-26 2023-10-25 S Sale
2.9
Palihapitiya Chamath
Large shareholder
67,213 -0.9%
1.76
US$118,382 		67,213 -0.9% 1.76 US$118,382
2023-10-26 2023-10-24 S Sale
2.9
Palihapitiya Chamath
Large shareholder
176,300 -2.2%
1.75
US$308,613 		176,300 -2.2% 1.75 US$308,613
2023-10-23 2023-10-23 S Sale
2.9
Palihapitiya Chamath
Large shareholder
160,300 -2.0%
1.83
US$293,429 		160,300 -2.0% 1.83 US$293,429
2023-10-23 2023-10-20 S Sale
2.9
Palihapitiya Chamath
Large shareholder
87,200 -1.1%
1.92
US$167,834 		87,200 -1.1% 1.92 US$167,834
2023-10-23 2023-10-19 S Sale
2.9
Palihapitiya Chamath
Large shareholder
200,000 -2.4%
2.19
US$438,700 		200,000 -2.4% 2.19 US$438,700
2023-10-18 2023-10-18 S Sale
2.9
Palihapitiya Chamath
Large shareholder
125,100 -1.5%
2.28
US$285,403 		125,100 -1.5% 2.28 US$285,403
2023-10-18 2023-10-17 S Sale
2.9
Palihapitiya Chamath
Large shareholder
106,400 -1.2%
2.83
US$301,357 		106,400 -1.2% 2.83 US$301,357
2023-10-18 2023-10-16 S Sale
2.9
Palihapitiya Chamath
Large shareholder
215,543 -2.5%
2.87
US$618,630 		215,543 -2.5% 2.87 US$618,630
2023-10-13 2023-10-13 S Sale
2.9
Palihapitiya Chamath
Large shareholder
250,000 -2.8%
2.67
US$667,525 		250,000 -2.8% 2.67 US$667,525
2023-10-13 2023-10-12 S Sale
2.9
Palihapitiya Chamath
Large shareholder
143,088 -1.6%
2.63
US$377,008 		143,088 -1.6% 2.63 US$377,008
2023-10-13 2023-10-12 S Sale
2.9
Palihapitiya Chamath
Large shareholder
18,775 -0.2%
3.14
US$58,999 		18,775 -0.2% 3.14 US$58,999
2023-10-13 2023-10-11 S Sale
2.9
Palihapitiya Chamath
Large shareholder
75,000 -0.8%
3.84
US$288,285 		75,000 -0.8% 3.84 US$288,285
2023-10-10 2023-10-10 S Sale
2.9
Palihapitiya Chamath
Large shareholder
75,000 -0.8%
4.34
US$325,162 		75,000 -0.8% 4.34 US$325,162
2023-10-10 2023-10-09 S Sale
2.9
Palihapitiya Chamath
Large shareholder
75,000 -0.8%
4.20
US$315,225 		75,000 -0.8% 4.20 US$315,225
2023-10-10 2023-10-06 S Sale
2.9
Palihapitiya Chamath
Large shareholder
75,000 -0.8%
4.48
US$336,360 		75,000 -0.8% 4.48 US$336,360
2023-10-10 2023-10-05 S Sale
2.9
Palihapitiya Chamath
Large shareholder
52,621 -0.6%
4.76
US$250,718 		52,621 -0.6% 4.76 US$250,718
2023-09-21 2023-09-19 S Sale
2.9
Palihapitiya Chamath
Large shareholder
1,700,000 -45.1%
5.47
US$9,299,000 		1,700,000 -45.1% 5.47 US$9,299,000
2022-09-08 2022-09-06 B Purchase
2.9
Cowen Aaron
Large shareholder
7,007 +0.1%
6.99
US$48,979 		7,007 +0.1% 6.99 US$48,979
Explore more

More insider trading research around ProKidney Corp

More insider trades in KY
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity